Graphical Abstract Access this article Similar content being viewed by others Data availability No datasets were generated or analysed during the current study
A single or dual receptor agonist, like semaglutide and tirzepatide, does not be the same as retatrutide
"As part of an extension trial published a year later, participants regained an average of two-thirds of the weight they shed within 12 months of discontinuing the drug." Within 12 months of discontinuing the drug, participants regained an average of two-thirds of the weight they shed
This protein cycling approach, front-loading protein toward the end of your weekly cycle when you can actually eat it, and supplementing with liquid protein during peak suppression, is a strategy that experienced researchers consistently report produces better body composition outcomes
People who participated in the trial either took a nine milligram or 12 milligram dose of retatrutide once a week for 68 weeks